Minnesota Rubber and Plastics Acquires Primasil Silicones Ltd.

Quadion LLC, d.b.a. Minnesota Rubber and Plastics (MRP), a leading provider of highly engineered elastomer and thermoplastic solutions for the medical, water and specialty industrial end markets, announced today its acquisition of Primasil Silicones Ltd. (Primasil), a Weobley, U.K.-based custom silicone rubber compounder, mixer and manufacturer specializing in the medical, HVAC and specialty industrial end markets.

“We’re thrilled to add Primasil, a company with four decades of silicone materials science expertise, to our family. Primasil’s custom material formulation, mixing and molding expertise will complement Minnesota Rubber and Plastic’s renowned materials science and molding capabilities. It will also provide a wide variety of new solutions for our clients,” said Jay Ward, CEO of Minnesota Rubber and Plastics.

Ward noted, “We have a long history of successfully serving our customers in Europe, and the addition of a highly technical production presence in the U.K. and Czech Republic will allow us to take our local capabilities to the next level. Not only will the acquisition augment our materials science and manufacturing capabilities, but it will also expand our global scope – particularly in the medical end market – and further our plans to expand our European footprint while we actively look to partner and acquire technical elastomer companies across the region.”

Primasil offers a wide range of custom materials, including platinum-cured silicone, conductive silicone, flourosilicone, high- and low-temperature silicone, low smoke and toxicity silicone and black rubber. Primasil’s proprietary silicone expertise will contribute to MRP’s materials science-driven Innovation Center, launching Spring 2022.

Furthermore, Primasil’s high precision manufacturing capabilities include cleanroom molding, extrusion and assembly as well as mixing, injection molded and proprietary gum silicone and liquid silicone rubber (LSR) products.

The addition of Primasil’s capabilities will complement MRP’s existing offerings, which include highly engineered elastomer and thermoplastic solutions for the medical device, water, food and beverage, infrastructure and other essential industries globally. MRP built its strong reputation over its more than 75-year history for designing, developing, manufacturing and assembling products for harsh environments, tight tolerances and technically demanding applications, including multi-material solutions and custom material formulations.

“The Primasil team is extremely excited about this opportunity. We look forward to working alongside our new colleagues at Minnesota Rubber and Plastics to continue serving our valued customers – in Europe and around the globe – with innovative technologies, great talent and more options than ever before,” said Steve Wheeler, Managing Director of Primasil. “We’re not just acquiring great products and capabilities to complement our current offerings; we’re adding a world-class team. We plan to extend ownership to all of the new colleagues we welcome onboard from Primasil,” added Ward.

Wheeler will continue to lead Primasil, reporting into the MRP organization. For more information about Minnesota Rubber and Plastics and its current offerings.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”